Difficulty: Medium
Average Score: 82%
Practice
The following is NOT true concerning bisphosphonates:
Correct answer
D
Rationale
In the context of chemotherapy drugs, the correct answer, D, that bisphosphonates may not be safely given in renal dysfunction is supported by the fact that these drugs are primarily excreted through the kidneys. In patients with renal dysfunction, there is a risk of drug accumulation leading to potential toxicity.
Option A is incorrect because bisphosphonates are used to decrease bone turnover in conditions like Paget's disease of bone. Option B is incorrect because alendronate, a bisphosphonate, inhibits an enzyme necessary for osteoclast survival, thus reducing bone resorption. Option C is incorrect as esophagitis is a known adverse effect of bisphosphonates, and taking them with a full glass of water while sitting upright helps reduce the risk of esophageal irritation.
Educationally, understanding the pharmacokinetics and contraindications of chemotherapy drugs like bisphosphonates is crucial for healthcare professionals to ensure safe and effective treatment for patients. It is essential to consider a patient's renal function when prescribing bisphosphonates to prevent any adverse effects associated with impaired drug clearance. This knowledge aids in optimizing patient care and minimizing potential risks during chemotherapy treatment.
Option A is incorrect because bisphosphonates are used to decrease bone turnover in conditions like Paget's disease of bone. Option B is incorrect because alendronate, a bisphosphonate, inhibits an enzyme necessary for osteoclast survival, thus reducing bone resorption. Option C is incorrect as esophagitis is a known adverse effect of bisphosphonates, and taking them with a full glass of water while sitting upright helps reduce the risk of esophageal irritation.
Educationally, understanding the pharmacokinetics and contraindications of chemotherapy drugs like bisphosphonates is crucial for healthcare professionals to ensure safe and effective treatment for patients. It is essential to consider a patient's renal function when prescribing bisphosphonates to prevent any adverse effects associated with impaired drug clearance. This knowledge aids in optimizing patient care and minimizing potential risks during chemotherapy treatment.